Market Access EMA’s strategy for speeding up drug approvals in the EU The EMA is implementing major changes to accelerate drug approvals in the EU, addressing delays that affect patients and businesses alike
Digital Power of digital technology and partnership to accelerate de... We are living through the fastest period of digital growth in human history. New technologies are transforming how we live, work, connect and innovate.
Sales & Marketing Balancing interests in launching medicines Launching new medicine at the right price is a complex issue, requiring a balance of interests
Market Access Innovative Medicines Fund and the opportunity for ICSs-indus... In June 2022, NHS England (NHSE) and the National Institute for Health and Care Excellence (NICE) launched the Innovative Medicines Fund (IMF).
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends